2.3(top 20%)
impact factor
268(top 50%)
papers
3.8K(top 20%)
citations
29(top 20%)
h-index
2.4(top 20%)
extended IF
417
all documents
4.2K
doc citations
48(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Targeting Notch signalling pathway of cancer stem cellsStem Cell Investigation2018234
2A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategiesStem Cell Investigation2019164
3Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesiclesStem Cell Investigation2017131
4Stem cell-based regenerative medicineStem Cell Investigation2019125
5Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair lossStem Cell Investigation2017101
6Current state of stem cell-based therapies: an overviewStem Cell Investigation202084
7Lung cancer stem cells—origin, characteristics and therapyStem Cell Investigation201881
8The past, present, and future of CRM1/XPO1 inhibitorsStem Cell Investigation201977
9Breast cancer stem cells—from origins to targeted therapyStem Cell Investigation201765
10Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemiaStem Cell Investigation201763
11Immune checkpoint blockade for hematologic malignancies: a reviewStem Cell Investigation201759
12Exosomal therapy—a new frontier in regenerative medicineStem Cell Investigation202155
13Extracellular vesicles and agingStem Cell Investigation201754
14Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cellsStem Cell Investigation201754
15Engineering of extracellular vesicles as drug delivery vehiclesStem Cell Investigation201754
16Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-βStem Cell Investigation201652
17Telomere shortening as a hallmark of stem cell senescenceStem Cell Investigation201949
18Breast cancer stem cells and the challenges of eradication: a review of novel therapiesStem Cell Investigation201848
19Adipose-derived stem cells from lean and obese humans show depot specific differences in their stem cell markers, exosome contents and senescence: role of protein kinase C delta (PKCδ) in adipose stem cell nicheStem Cell Investigation201641
20Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the uglyStem Cell Investigation201740
21Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaStem Cell Investigation201639
22Stem-cell extracellular vesicles and lung repairStem Cell Investigation201739
23Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of Retinitis PigmentosaStem Cell Investigation201838
24The biomarkers of leukemia stem cells in acute myeloid leukemiaStem Cell Investigation201737
25Stem cell extracellular vesicles and kidney injuryStem Cell Investigation201737
26Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemiaStem Cell Investigation201736
27Adverse events, side effects and complications in mesenchymal stromal cell-based therapiesStem Cell Investigation036
28microRNA regulation of human pancreatic cancer stem cellsStem Cell Investigation201734
29GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenanceStem Cell Investigation201734
30Platelet-rich plasma—an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literatureStem Cell Investigation201734
31Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)Stem Cell Investigation201734
32Mini and customized low-cost bioreactors for optimized high-throughput generation of tissue organoidsStem Cell Investigation201832
33Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemiaStem Cell Investigation201731
34TNF-α, a good or bad factor in hematological diseases?Stem Cell Investigation201431
35Mesenchymal stem cells as delivery vectors for anti-tumor therapyStem Cell Investigation201531
36Stem cell manipulation, gene therapy and the risk of cancer stem cell emergenceStem Cell Investigation201730
37Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiationStem Cell Investigation201529
38Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistanceStem Cell Investigation201728
39Cancer stem cells: progress and challenges in lung cancerStem Cell Investigation201428
40Epithelial-mesenchymal plasticity—engaging stemness in an interplay of phenotypesStem Cell Investigation201927
41The role of mesenchymal stem/progenitor cells in sarcoma: update and disputeStem Cell Investigation201427
42Current development of chimeric antigen receptor T-cell therapyStem Cell Investigation201826
43Loss of heterogeneity, quiescence, and differentiation in muscle stem cellsStem Cell Investigation201825
44Hypomethylating agents after allogeneic blood stem cell transplantationStem Cell Investigation201624
45Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implicationsStem Cell Investigation201624
46Cell-based therapy for idiopathic pulmonary fibrosisStem Cell Investigation201924
47Alopecia and platelet-derived therapiesStem Cell Investigation201723
48Cancer stem cells and exosome signalingStem Cell Investigation201523
49Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanomaStem Cell Investigation201722
50Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotypeStem Cell Investigation201922